575 related articles for article (PubMed ID: 15209766)
1. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
[TBL] [Abstract][Full Text] [Related]
2. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
Chakarova N; Tankova T; Atanassova I; Dakovska L
Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
4. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
Lemieux S; Bédard A; Piché MÈ; Weisnagel SJ; Corneau L; Bergeron J
Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
6. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
7. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.
Meyer C; Pimenta W; Woerle HJ; Van Haeften T; Szoke E; Mitrakou A; Gerich J
Diabetes Care; 2006 Aug; 29(8):1909-14. PubMed ID: 16873801
[TBL] [Abstract][Full Text] [Related]
8. Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study-CVD.
Xu L; Jiang CQ; Lam TH; Cheng KK; Yue XJ; Lin JM; Zhang WS; Thomas GN
Metabolism; 2010 Mar; 59(3):367-72. PubMed ID: 19828159
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in lipid profiles in relation to the progression of glucose abnormalities.
Carnevale Schianca GP; Fra GP; Colli E; Bigliocca M; Mella R; Scaglia E; Bartoli E
J Diabetes; 2012 Mar; 4(1):95-101. PubMed ID: 21951548
[TBL] [Abstract][Full Text] [Related]
10. Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up.
Alvarsson M; Hilding A; Ostenson CG
Diabet Med; 2009 Apr; 26(4):345-53. PubMed ID: 19388963
[TBL] [Abstract][Full Text] [Related]
11. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold.
Andreozzi F; Succurro E; Mancuso MR; Perticone M; Sciacqua A; Perticone F; Sesti G
Diabetes Metab Res Rev; 2007 Oct; 23(7):547-50. PubMed ID: 17311284
[TBL] [Abstract][Full Text] [Related]
13. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
[TBL] [Abstract][Full Text] [Related]
14. Impaired glucose tolerance is not associated with lipid intolerance.
Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Alviggi L; Gnasso A; Consoli A; Cavalot F; Cavallo MG; Leonetti F; Giaccari A; Del Prato S;
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660
[TBL] [Abstract][Full Text] [Related]
16. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
Muntner P; He J; Chen J; Fonseca V; Whelton PK
Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
[TBL] [Abstract][Full Text] [Related]
18. Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism.
Moors CC; van der Zijl NJ; Diamant M; Blaak EE; Goossens GH
Int J Obes (Lond); 2012 May; 36(5):709-17. PubMed ID: 21712806
[TBL] [Abstract][Full Text] [Related]
19. Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation.
Pascot A; Després JP; Lemieux I; Alméras N; Bergeron J; Nadeau A; Prud'homme D; Tremblay A; Lemieux S
Diabetes Care; 2001 May; 24(5):902-8. PubMed ID: 11347752
[TBL] [Abstract][Full Text] [Related]
20. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
